ASH 2023: MRD Highlights in BioPharma Drug Development

Read More

Permissive HLA-DPB1 mismatches in HCT depend on immunopeptidome divergence and editing by HLA-DM

Meurer T., et al.
November 2020
Authors and Affiliates
Thuja Meurer 1, Pietro Crivello 2, Maximilian Frederik Metzing 1, Michel Kester 3, Dominik A Megger 4, Weiqiang Chen 4, P A van Veelen 5, Peter van Balen 3, Astrid Westendorf 6, Georg Homa 1, Sophia E Layer 1, Amin T Turki 1, Marieke Griffioen 3, Peter A Horn 1, Barbara Sitek 7, Dietrich W Beelen 8, J H Frederik Falkenburg 9, Esteban Arrieta-Bolaños 10, Katharina Fleischhauer 10; 1 University Hospital Essen, Essen, Germany. 2 Essen University Hospital, Essen, Germany. 3 Leiden University Medical Center, Leiden, Netherlands. 4 Medical Proteome Center, Ruhr University Bochum, Bochum, Germany. 5 Centre for Medical Systems Biology, Leiden University Medical Center, Leiden, Netherlands. 6 University of Duisburg-Essen, University Hospital Essen, Essen, Germany. 7 Ruhr-University Bochum. 8 University Hospital of Essen, Essen, Germany. 9 Leiden University of Medical Center, Leiden, Netherlands. 10 German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Germany.